|
|
||||||||
Received January 28, 2008. Accepted for publication October 31, 2008.
Acknowledgments: We thank Dr. Sergio Recuenco (Centers for Disease Control and Prevention, Atlanta, GA) Dr. Ofelia Zegarra-Moro from (Kansas State University, Manhattan, KS), and Lilia Cabrera (A.B. Prisma, Lima, Peru) for useful advice.
Disclosure: The authors report no conflicts of interest with the study.
* Address correspondence to Manuel H. Moro, Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892. E-mail: manuel.moro{at}nih.gov
Authors addresses: Pedro L. Moro, Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop D26, Atlanta, GA 30333, E-mail: pmoro{at}cdc.gov. Jyotsna Shah, and Nick Harris, IGeneX Inc., 797 San Antonio Road, Palo Alto, CA 94303, E-mails: jyotsna{at}aol.com and nharris{at}aol.com. Olga Li, Laboratorio de Patología Clínica, Facultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima, Peru, E-mail: Olgalie{at}hotmail.com. Robert H. Gilman, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room W5515, Baltimore, MD 21205, E-mail: rgilman{at}jhsph.edu. Manuel H. Moro, Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, 6701 Democracy Boulevard, Bethesda, MD 20892, E-mail: manuel.moro{at}nih.gov.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |